Rivaroxaban CAS 366789-02-8 Puritas >99.5% (HPLC) Factory API Quality

Description:

Nomen chemicum: Rivaroxaban

CAS: 366789-02-8

Puritas: >99.5% (HPLC)

Aspectus: Alba vel fere Alba pulveris

API High Quality, Commercial Production

E-Mail: alvin@ruifuchem.com


Product Detail

Related Products

Product Tags

Descriptio:

Chemical Properties:

Nomen chemicum Rivaroxaban
Synonyma (S) -Rivaroxaban;(S) -5-Chloro-N-((2-oxo-3-(4-(3-oxomorpholino)phenyl)-oxazolidin-5-yl)methyl)thiophene-2-carbox;BAV 59-7939
CAS Number 366789-02-8
Stock Status In Stock, Productio Ascendite ad Tons
Formulae hypotheticae C19H18ClN3O5S
M. Pondus 435.88
Brand Ruifu Chemical

Specifications:

Item Specifications
Aspectus Alba aut fere Alba pulveris
Lepidium sativum Infrared effusio Rivaroxaban respondet signis referentibus
Lepidium sativum B * Retentionis tempus praecipui solutionis specimen summae correspondet solutioni convenientiae systematis, prout in puritate enantiomericana obtinetur.
Puritas Enantiomeric RVX RC01: ≤0.15%
Humor (KF) ≤0.50%
Cinis sulphated ≤0.10%
Metalla gravis ≤20ppm
Acidum acetic ≤5000ppm
Substantiae cognatae (HPLC)
RVX RC02 ≤0.15%
RVX RC03 ≤0.15%
RVX RC04 ≤0.15%
RVX RC05 ≤0.15%
RVX RC06 ≤0.15%
RVX RC07 ≤0.15%
RVX RC08 ≤0.15%
Alia individua immunditia ≤0.10%
Totalis immunditias <0.50%
RELICTUM Solvents (GC)
Ethanol ≤5000ppm
Toluene ≤890ppm
Triethylamine ≤320ppm
Puritas / Analysis Methodus >99.5% (HPLC) (on anhydrous basis)
Test Standard Enterprise Standard
Consuetudinem API;Antithrombotic medicamentum;FXa Inhibitor

Sarcina & Repono:

sarcina: Utrem, aluminium foil, sacculum, 25kg/cardboard Drum, vel secundum exigentiam emptoris.

Repono Condition:Repone in vasis signatis in loco frigido et sicco;A luce et humore protege.

commoda:

1

FAQ:

Applicatio:

Rivaroxaban(CAS:366789-02-8) (Xarelto, Bayer) oralis anticoagulans est.Xa factor inhibitor oretenus directus est activus.Rivaroxaban significatur per "tractationem venae profundae thrombosis et embolismi pulmonis, et praeventionis recurrentis venae altae thrombosis et embolismi pulmonis in adultis".Ad tractationem initialem embolismi pulmonis acuti, dosis rivaroxabani commendatus est 15 mg bis cotidie pro primis 21 diebus, deinde 20 mg semel cotidie ad curatio continua et praeventionis thromboembolismi venarum recurrentis.Fibrillatio non-valvular atrialis (NVAF) ad praecavendam ictum & embolismum systemicum.Curatio acuta VTE & praeventionis VTE recurrentis [pro venae profundae thrombosis (DVT) et embolismi pulmonis (PE)].Praeventio venarum thromboembolicarum eventus (VTE) in totali coxae vel genu chirurgiae electivae (THR, TKR).

Epistulam tuam hic scribe et mitte nobis